Y-ECCO Literature Review: PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signaling and exacerbates experimental colitis

Y-ECCO Literature Review: Proteolytic cleavage and loss of function of biologic agents that neutralize tumor necrosis factor in the mucosa of patients with Inflammatory Bowel Disease

Y-ECCO Literature Review: Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn’s disease from UC.

Y-ECCO Literature Review: Rapid fucosylation of intestinal epithelium sustains host–commensal symbiosis in sickness

Y-ECCO Literature Review: Recombinant human erythropoietin in patients with infl ammatory bowel disease and refractory anemia: A 15-year single-center experience

Y-ECCO Literature Review: Risk for colorectal neoplasia in patients with colonic Crohn’s disease and concomitant primary sclerosing cholangitis

Y-ECCO Literature Review: Risk of cancer in patients with inflammatory bowel disease and venous thromboembolism: a nationwide cohort study

Y-ECCO Literature Review: Risk of colorectal cancer and small bowel adenocarcinoma in Crohn’s disease: A population-based study from western Hungary 1977–2008.

Y-ECCO Literature Review: Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with Inflammatory Bowel Disease

Y-ECCO Literature Review: Risk of melanoma and nonmelanoma skin cancer among patients with Inflammatory Bowel Disease

Y-ECCO Literature Review: Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn’s Disease

Y-ECCO Literature Review: Subcutaneus Golimumab Maintains Clinical Response in Patients with Moderate-To-Severe Ulcerative Colitis

Y-ECCO Literature Review: Switch to adalimumab in patients with Crohn’s disease controlled by maintenance infliximab: prospective randomised SWITCH trial

Y-ECCO Literature Review: Systematic review of effects of withdrawal of immunomodulators or biologic agents from patients with inflammatory bowel disease

Y-ECCO Literature Review: The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in Inflammatory Bowel Disease: The ATLAS study

Y-ECCO Literature Review: The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric infl ammatory bowel disease

Y-ECCO Literature Review: The safety of vedolizumab for Ulcerative Colitis and Crohn’s Disease

Y-ECCO Literature Review: Tofacitinib, an oral Janus kinases inhibitor, in active Ulcerative Colitis

Y-ECCO Literature Review: Tofacitinib, an oral Janus kinases inhibitor, in active Ulcerative Colitis

Y-ECCO Literature Review: Ustekinumab induction and maintenance therapy in refractory Crohn’s Disease